Observed Signal · Sep 17, 2026 · Funding · Source: EU-Startups (European Venture) · Impact: 2/5 · Sentiment: Positive
Health Force Raises €4.2M for Hospital AI Agents
Barcelona-based Health Force, a HealthTech startup, raised €4.2 million in Seed funding to expand its enterprise-grade AI agents for hospital operations. The round was led by LUMO Labs with participation from Step Venture, Next Tier Ventures, Target Global, and Calm/Storm. Founded in 2022 in Vienna, Health Force automates administrative tasks in hospitals, such as prior-authorisation checks, claims processing, and regulatory reporting. The company reports that its AI agents handle 75% of cases autonomously and are deployed at leading Italian hospital groups, including Humanitas and Gruppo San Donato, processing over 200,000 patient cases annually. The company plans to use the funds to expand into new workflows and European markets including Germany, France, and Spain.
Relevant to AI in healthcare, but not directly AdTech/MarTech; illustrates broader AI agent adoption trends but lacks direct advertising or marketing relevance.
Track Real-Time Funding Signals & Market Shifts
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Health Force raised €4.2 million in Seed funding.
- The investment round was led by LUMO Labs, with participation from Step Venture, Next Tier Ventures, Target Global, and Calm/Storm.
- Health Force is a Barcelona-based HealthTech startup founded in 2022.
- The company's AI agents automate hospital operations including claims processing and regulatory reporting.
- Health Force's agents handle over 200,000 patient cases per year across hospital groups in Italy.
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Biolevate raises €30M Series A for life sciences AI
Biolevate, a Paris-based life sciences AI company, has raised €30 million in Series A funding to scale its enterprise agentic AI platform designed to automate scientific and regulatory workflows. The round was co-led by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund, Station F, and existing investor EQT Ventures. The platform enables life sciences organizations to run thousands of concurrent AI agents, with outputs grounded in source evidence and human oversight, facilitating use in regulated environments. Since its 2024 seed round, Biolevate has expanded to over a dozen enterprise customers, achieving significant efficiency gains in literature reviews and regulatory intelligence. The company is opening a US office in Boston, has doubled headcount, and plans to double again, while also filing patents in Europe.
HelmGuard Raises $7.3M Seed for AI Compliance Automation
London-based GRC startup HelmGuard has raised $7.3 million in seed funding to expand its platform that uses AI agents to automate risk and compliance assessments. The round was co-led by Infinity Ventures and Frontline, with participation from FinTech Collective, Stage 2 Capital, and Entrepreneurs First. HelmGuard's platform collects and analyzes risk information directly from companies' systems, targeting regulated industries such as financial services, insurance, and healthcare. The technology aims to reduce manual work in third-party risk management and control gap assessments. The company also plans to develop an agent assurance layer to monitor risks associated with AI agents and a Verified Risk Network for continuous exchange of verified risk information. The funding will support US expansion, with offices in New York and San Francisco, and further development of its technology.
Tandem Health Raises $100M Series B Led by EU Fund
Stockholm-based Tandem Health, a HealthTech startup developing an AI-native operating system for European clinics, has raised $100 million (€86.49 million) in Series B funding. The round was led by EQT's Scaleup Europe Fund, marking its first healthcare investment, with participation from existing investors Kinnevik, Northzone, Amino Collective, and Visionaries. Tandem's AI co-pilot assists clinicians by generating medical notes, preparing patient summaries, aiding clinical decisions, and automating documentation; it is certified as a Class IIa medical device under EU regulations. Used by over 10,000 care organizations across 14 European markets, including the NHS, Ramsay Santé, and Humanitas, the company has now raised a total of $160 million following a $50 million Series A last year. The funding will support European expansion, growth of its clinician-led team, and the evolution into a comprehensive AI-native clinic operating system.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.